Helping People Live Healthier, More Productive Lives

Trusted for nearly 60 years, Phillips-Medisize, a Molex company, is a global leader in front-end design, development and manufacturing solutions for highly regulated industries — pharma, in vitro diagnostics, med tech, consumer, automotive and defense.

Operating as a single integrated collaborator, we help our customers reduce risk and achieve product realization quickly and efficiently. Our innovation, quality and reliability enhance the lives of millions of people around the world.

From Concept to Culture

Our integrated end-to-end portfolio of design, development, and manufacturing capabilities is built on a solid foundation of unparalleled execution, global scale, and agility.  Continual reinvestment in new technologies helps us apply award-winning, rapid innovation to solve the most complex engineering challenges. 

Our customer-first culture puts you at the center surrounded by industry-leading program management rigor and a robust global quality management system that reduces risk from inception.  We give you the confidence to deliver innovative products that realize exceptional outcomes.

Phillips-Medisize Quick Facts

  • Founded in 1964 in Phillips, WI
  • 6 thousand employees worldwide
  • 24 manufacturing locations in 11 countries, including 5 R&D centers globally
  • 2.5M+ square feet of manufacturing space
  • Class 7 & 8 cleanrooms and tool building sites

Global Reach and Resources

Backed by the combined resources of Molex, and its parent company Koch Industries, Phillips-Medisize is a global company of more than 6,000 professionals with expertise and experience in design, product development, manufacturing, tool build and new product introduction. We are ready to serve customers across the globe.

Making a Real-World Difference

Collaborating with Phillips-Medisize means that our customers can reach the market faster with products that change lives. In a single year, we helped:



1.3 Billion

Doses of Life-saving drug Therapies

186 Million

Patients screened for cancer

25 Million

Care of Insulin-Dependent Diabetic Patients

5 Million

Cardiovascular surgeries enabled with technology

19 Million

Emergency doses of life-saving therapies

114 Million

Diabetic patients provided with continuous glucose monitors


Our collaborative, customer-centric environment places a strong emphasis on efficiency, quality, speed and agility.


Our passionate, experienced team drives innovation and quality across our global organization.


See how we’re leading sustainable design and reducing waste across the product lifecycle.

Learn More


Get the latest industry and company news, events and information.

View All

Recognized for Innovation and Excellence